Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Meihua International Medical Technologies Co Ltd ( (MHUAF) ) has shared an announcement.
Meihua International Medical Technologies Co., Ltd., a China-based medical device maker whose Class A ordinary shares had been listed on Nasdaq, has seen its stock shifted to trading on the OTC Marketplace under the symbol MHUAF after a Nasdaq staff decision in December 2025. The company, which files annual reports as a foreign private issuer in the U.S., has its principal executive office in Yangzhou, Jiangsu province in the People’s Republic of China.
On December 2, 2025, Nasdaq staff determined to delist Meihua International’s securities, leading to a trading suspension on Nasdaq and commencement of OTC trading on December 9, 2025. The company appealed at a January 27, 2026 hearing, but on February 24, 2026 a Nasdaq Hearings Panel denied its request to reinstate trading and upheld the delisting.
In response to the adverse panel decision, Meihua International on March 2, 2026 sought further review by the Nasdaq Listing and Hearing Review Council. The move extends the company’s regulatory battle over its U.S. listing status, leaving investors facing continued trading on the less regulated OTC market while the appeal process runs its course.
The most recent analyst rating on (MHUAF) stock is a Hold with a $12.00 price target. To see the full list of analyst forecasts on Meihua International Medical Technologies Co Ltd stock, see the MHUAF Stock Forecast page.
Spark’s Take on MHUAF Stock
According to Spark, TipRanks’ AI Analyst, MHUAF is a Neutral.
The score is driven primarily by solid financial performance (strong operating margins and low leverage) tempered by inconsistent free cash flow. Technicals detract due to weak longer-term trend signals and negative MACD despite stretched momentum readings, while the very low P/E supports the overall score.
To see Spark’s full report on MHUAF stock, click here.
More about Meihua International Medical Technologies Co Ltd
Meihua International Medical Technologies Co., Ltd. is a China-based medical device company headquartered in Yangzhou, Jiangsu province. The company is listed in the U.S. as a foreign private issuer and its Class A ordinary shares previously traded on the Nasdaq Stock Market before being moved to the over-the-counter marketplace.
Average Trading Volume: 8,701
Technical Sentiment Signal: Sell
Current Market Cap: $7.72M
For detailed information about MHUAF stock, go to TipRanks’ Stock Analysis page.